Apparatus and methods for delivery of braided prostheses

Information

  • Patent Grant
  • 7357812
  • Patent Number
    7,357,812
  • Date Filed
    Thursday, October 14, 2004
    19 years ago
  • Date Issued
    Tuesday, April 15, 2008
    16 years ago
Abstract
Blood vessels and other body lumens are expanded using an evertible braided prosthesis. The braided prosthesis is delivered to the blood vessel in a radially collapsed configuration. A leading edge of the braided prosthesis is then everted so that it expands as it is advanced through the blood vessel. Optionally, the prosthesis can be provided with a biologically active substance in order to inhibit hyperplasia or have other desired biological effects.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention relates generally to medical devices and methods. More particularly, the present invention relates to apparatus and methods for delivering braided and other everting prostheses within a body lumen, such as a blood vessel.


Coronary artery disease is the leading cause of death and morbidity in the United States and Western society. In particular, atherosclerosis in the coronary arteries can cause myocardial infarction, commonly referred to as a heart attack, which can be immediately fatal or even if survived, cause damage to the heart which can incapacitate the patient.


While coronary artery bypass surgery can be an effective treatment for stenosed arteries resulting from atherosclerosis or other causes, it is a highly invasive, costly procedure, which typically requires substantial hospital and recovery time. Percutaneous transluminal coronary angioplasty, commonly referred to as balloon angioplasty, is less invasive, less traumatic, and significantly less expensive than bypass surgery. Heretofore, however, balloon angioplasty has not been considered as effective a treatment as bypass surgery. The effectiveness of balloon angioplasty, however, has improved significantly with the introduction of stenting, which involves the placement of a scaffold structure within the artery which has been treated by balloon angioplasty. The stent inhibits abrupt reclosure of the artery and has some benefit in inhibiting subsequent restenosis resulting from hyperplasia. Recently, experimental trials have demonstrated that coating stents with anti-proliferative drugs, such as paclitaxel, can significantly reduce the occurrence of hyperplasia in angioplasty treated coronary arteries which have been stented with the coated stents.


While the combination of balloon angioplasty with drug-coated stents holds great promise, significant challenges still remain. Of particular interest to the present invention, the treatment of extended or disseminated disease within an artery remains problematic. Most stents have a fixed length, typically in the range from 10 mm to 30 mm, and the placement of multiple stents to treat disease over a longer length requires the successive use of multiple balloon stent delivery catheters. Moreover, it can be difficult to stent an angioplasty-treated region of a blood vessel with the optimum stent length.


For these reasons, it would be desirable to provide improved stents, stent delivery systems, stenting methods, and the like, for the treatment of patients having coronary artery disease, as well as other occlusive diseases of the vasculature and other body lumens. In particular, it would be desirable to provide stents, delivery systems, and methods for the treatment of disseminated and variable length stenotic regions within the vasculature. For example, it would be desirable to provide a practical method which permits a physician to deliver extended lengths of braided prostheses to blood vessels and other body lumens. At least some of these objectives will be met by the inventions described hereinafter.


2. Description of the Background Art


U.S. Pat. No. 5,755,772 describes a tubular prosthesis and method for its implantation by positioning the prosthesis at a target site, and everting an end session to lock the stent after expansion has been completed; and U.S. Pat. No. 5,769,882 describes conformable tubular prostheses and their placement in blood vessels.


BRIEF SUMMARY OF THE INVENTION

The present invention provides methods and apparatus for the stenting of body lumens, typically blood vessels, and more typically coronary arteries. The methods and systems will also find significant use in the peripheral vasculature, the cerebral vasculature, and in other ducts, such as the biliary duct, the fallopian tubes, and the like. The terms “stent” and “stenting” are defined to include any of the wide variety of expandable scaffolds which are designed to be intraluminally introduced to a treatment site and expanded in situ to apply a radially outward force against the inner wall of the body lumen at that site. Stents commonly comprise an open lattice structure, typically formed from a malleable or elastic metal.


The stents of the present invention will comprise evertible structures which radially expand upon eversion to assume a non-collapsible diameter which remains in place within the body lumen to support the luminal wall. Typically, the evertible stent structures will comprise braided structures, but other structures, such as counterwound helices, will also be capable of eversion. In some instances, laser cut helical and other patterned metal tubes, particularly those formed from nickel titanium and other shape memory alloys, may be used. Thin wall tubes formed from polymeric materials, such as polyethylene terephthalate (PET), expanded polytetrafluoroethyolene (e PTFE), may also find use, even without patterning.


The braided and other evertible stent structures of the present invention may be formed from metals, including both malleable metals and elastic metals, such as shape memory metals, as well as from polymeric materials. Usually, the braided structures will comprise individual ribbons of the desired material which are interwoven to form a braid so that the braid may be axially elongated to assume a narrow diameter configuration and thereafter be everted to assume a larger diameter configuration. By “evert” it is meant that a leading edge of the prosthesis is turned outwardly and backwardly relative to the narrow diameter portion thereof. In the preferred methods and apparatus of the present invention, as described in more detail below, such eversion will be achieved by initially holding the prosthesis in its narrow diameter configuration with the leading portion everted and fixed to an outer portion of a catheter. This leading portion is referred to as the “fixed end.” The remainder of the prosthesis which remains in its narrow diameter configuration is held within a passage or lumen of a delivery catheter, and means are provided for pushing the “advancable end” of the prosthesis which is in the lumen forwardly relative to the fixed end. In this way, the leading edge of the prosthesis moves forward continuously relative to the fixed end as it everts radially outwardly.


The use of such braided and other evertible prostheses provides a number of advantages. For example, the braided structure is highly flexible, particularly in its narrow diameter configuration, allowing the introduction of relatively long stent segments without significantly limiting the ability of the delivery catheter to pass through torturous regions of the vasculature or other body lumens. Additionally, by everting the prosthesis so that its outer portion remains stationary relative to the fixed end (and thus also relative to the delivery catheter), the stent will be able to pass through relatively small body lumens since it advances much like a tractor tread in moving forwardly through the lumen. In the case of vascular treatments, the stents of the present invention will usually be used following other primary interventions, such as angioplasty, atherectomy, aneurysm repair, or the like. It will be possible, however, in certain instances, to deliver the stent without prior intervention because of the ability to advance through tight lesions and to dilate the lesion as it passes therethrough.


Usually, the methods and apparatus of the present invention will be used to deliver a single stent having a predetermined length. In other instances, however, it will be possible to provide a means for severing the stent on the catheter itself. In such cases, the methods and apparatus of the present invention will be capable of delivering variable lengths of stent depending on the nature and extent of the disease being treated. That is, the apparatus will be used to deliver the stent under fluoroscopic or other observation, and after a desired length of stent has been deployed, the deployed length can be severed from the length which remains carried within the delivery catheter.


In one aspect of the present invention, a method for delivering a prosthesis to a body lumen comprises positioning a metallic tubular prosthesis at a target site within the body lumen. The prosthesis is then everted so that an inside surface is exposed radially outwardly and advanced over a length of the wall of the body lumen. Usually, positioning comprises introducing a delivery catheter having a passage which carries the tubular prosthesis at least partly in a radially collapsed configuration. Everting usually comprises pushing the tubular prosthesis from the catheter so that a leading portion of the prosthesis everts and radially expands as it exits the catheter or passage. This is usually accomplished by forwardly advancing a portion of the catheter to push the prosthesis from the catheter. In a preferred aspect of the present invention, an advancable segment of the prosthesis is carried in the passage in the radially collapsed configuration. A fixed end of the prosthesis is held stationary relative to the catheter in a partially everted configuration. Everting then comprises pushing a proximal end (i.e., an end or portion of the prosthesis which is radially collapsed within the delivery catheter) to cause a middle portion of the prosthesis to progressively evert and advance distally relative to the fixed end. In the case of braided prostheses, the braided structure will shorten as the radius expands so that the “advancable” proximal end prosthesis is pushed forward at a rate which is faster than the rate at which the everted prosthesis covers the wall of the body lumen. In preferred embodiments, the prosthesis releases an active substance which inhibits hyperplasia after the prosthesis has been placed in the body lumen.


In another aspect of the present invention, a method for delivering a stent to a blood vessel comprises positioning the stent at a target site within the blood vessel and everting the stent so that an inside surface is exposed radially outwardly and advanced over a length of a wall of the blood vessel. The stent, in turn, inhibits restenosis in the blood vessel.


In another aspect of the present invention, a method for delivering a prosthesis to a body lumen involves positioning a tubular prosthesis at a target site within the body lumen, the tubular prosthesis having a total length. The tubular prosthesis is then everted so that an inside surface is exposed radially outwardly and a desired length of the tubular prosthesis is advanced over a length of a wall of the body lumen, the desired length being less than the total length. The method then includes severing a portion of the tubular prosthesis having the desired length to allow the portion to remain in the body lumen.


In another aspect of the present invention, a method for delivering a prosthesis to a body lumen involves positioning a delivery catheter carrying a tubular prosthesis at a target site within the body lumen, everting the tubular prosthesis so that an inside surface is exposed radially outwardly and advanced over a desired length of a wall of the body lumen, and deploying a portion of the tubular prosthesis having the desired length. A second length of the tubular prosthesis remains carried within the delivery catheter.


In another aspect of the present invention, apparatus for delivering a prosthesis to a body lumen includes a catheter having a passage, a metallic tubular prosthesis carried in the passage at least partially in a radially collapsed configuration, and a slidable member in the catheter for advancing the prosthesis from the passage so that the prosthesis everts and radially expands as it is advanced. In some embodiments, the metallic tubular prosthesis is a shape memory metal. In some embodiments, the metallic tubular prosthesis comprises a braided metal structure. Alternatively, the metallic tubular prosthesis may comprise an open lattice structure.


In yet another embodiment of the present invention, apparatus for delivering a prosthesis to a blood vessel includes a catheter having a passage, a stent carried in the passage at least partially in a radially collapsed configuration, and a slidable member in the catheter for advancing the prosthesis from the passage so that said prosthesis everts and radially expands as it is advanced. The stent is configured to inhibit restenosis in the blood vessel.


In another aspect of the invention, apparatus for delivering a prosthesis to a body lumen includes a catheter having a passage, a tubular prosthesis carried in the passage at least partially in a radially collapsed configuration, a slidable member in the catheter for advancing the prosthesis from the passage so that said prosthesis everts and radially expands as it is advanced, and a severing member in the catheter for severing a portion of the prosthesis to allow the portion to remain in the body lumen while a second portion of the prosthesis remains carried in the catheter.


These and other aspects and embodiments of the present invention will be described in further detail below, with reference to the attached drawing figures.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view illustrating a stent delivery catheter constructed in accordance with the principles of the present invention.



FIGS. 2A-2D illustrate use of the catheter in FIG. 1 for deploying a braided stent within a stenosed region in a blood vessel.





DETAILED DESCRIPTION OF THE INVENTION

Referring now to FIG. 1, the stent delivery catheter 10 comprises a catheter body 12 having a proximal end 14 and a distal end 16. The catheter body 12 is formed from a conventional catheter material, such as a natural or synthetic polymer, such as silicone rubber, polyethylene, polyvinylchloride, polyurethane, polyester, polytetrafluoroethylene, nylon, and the like. The body may be formed as a composite having one or more reinforcement layers incorporated within a polymeric shell in order to enhance strength, flexibility, and toughness. For intravascular use, the catheter body will typically have a length in the range from 40 cm to 150 cm, usually being between 40 cm and 120 cm for peripheral blood vessels and between 110 cm and 150 cm for coronary arteries. The outer diameter of the catheter body may vary depending on the intended use, typically being between 3 French and 15 French, usually from 5 French to 9 French (one French=0.33 mm).


Catheter 10 further comprises a handle 18 at its proximal end 14. The handle has a guidewire port 20 at its distal end as well as a handle grip 24 which is actuable to extend and release evertible prosthesis 30 from the distal end 16. The catheter body 12 comprises an outer tube 32, a middle tube 34 which coaxially and slidably mounted within a lumen of the outer tube 32, and an inner tube 36 which is slidably and coaxially mounted within a lumen of the middle tube 34. Inner tube 36 has a central lumen for receiving a guidewire, as described in detail below.


Referring now to FIGS. 2A-2D, delivery of the prosthesis 30 within a stenosed region SR of a blood vessel BV is described. The distal end 16 of the catheter 10 is introduced over a guidewire GW to the stenosed region SR as shown in FIG. 2A.


At that point, the prosthesis 30 is advanced forwardly or distally into the stenosed region SR of the blood vessel BV, as shown in FIG. 2B. In particular, both the inner tube 36 and the middle tube 34 are advanced forwardly or distally relative to the outer tube 32. This causes the leading edge 40 of the prosthesis 30 to advance into the stenosed region SR, engaging and partially dilating the lumen wall within this region.


As the inner tube 36 and middle tube 34 are further advanced, as shown in FIG. 2C, the leading edge 40 of the prosthesis advances out through the other end of the stenosed region SR. During this entire deployment, fixed end 42 of the prosthesis has remained on the distal end of the outer tube 32 of the delivery catheter 10.


Once the prosthesis 30 is fully deployed, the outer tube 32 would be disengaged from the fixed end 42 of the prosthesis, e.g., by rotating or otherwise separating the catheter from the prosthesis, leaving the prosthesis 30 in place, as shown in FIG. 2D. As can be seen in FIG. 2D, the deployment of the prosthesis 30 has dilated the stenotic region. At this point, if the dilation is insufficient, or further anchoring of the prosthesis 30 is desired, a balloon or other expandable member may be expanded within the prosthesis 30 in a conventional manner. In one embodiment, for example, a balloon may be coupled with the outer tube 32 in such a way as to allow the balloon to be inflated to further anchor the prosthesis 30 in place.


It will be appreciated that the lengths, pitches, adjacent spacings, and the like, of the braided and other elements deployed according to the methods of the present invention can be controlled at the discretion of the treating physician. Thus, the methods and apparatus of the present invention provide useful flexibility for the treating physician to treat extended and disseminated disease in the vasculature and other body lumens.


Although the foregoing invention has been described in some detail by way of illustration and example, for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practices within the scope of the appended claims.

Claims
  • 1. A method for delivering a prosthesis to a body lumen, said method comprising: positioning a delivery catheter carrying a tubular prosthesis at a target site within the body lumen;everting the tubular prosthesis so that an inside surface is exposed radially outwardly and advanced over a desired length of a wall of the body lumen, wherein the prosthesis radially expands into engagement with an inner wall of the body lumen and applies a radially outward force against the inner wall as the prosthesis is everted and advanced; anddeploying a portion of the tubular prosthesis having the desired length, wherein a second length of the tubular prosthesis remains carried within the delivery catheter.
  • 2. The method of claim 1, further comprising the step of separating a portion of the tubular prosthesis having the desired length from the second length on the delivery catheter.
  • 3. The method of claim 2, wherein the step of separating comprises severing the tubular prosthesis.
  • 4. The method of claim 3, wherein a severing member is disposed on the delivery catheter and adapted to sever the tubular prosthesis.
  • 5. The method of claim 1, further comprising releasing a therapeutic agent from the desired length of the prosthesis after it has been deployed from the delivery catheter.
  • 6. The method of claim 5, wherein the therapeutic agent inhibits hyperplasia.
  • 7. The method of claim 1, wherein positioning comprises carrying the tubular prosthesis in a radially collapsed configuration.
  • 8. The method of claim 1, wherein everting comprises pushing the tubular prosthesis from the catheter.
  • 9. The method of claim 1, further comprising expanding an expandable member within the deployed portion to anchor the deployed portion into the body lumen.
  • 10. The method of claim 9, wherein expanding an expandable member comprises inflating a balloon coupled to the delivery catheter.
  • 11. An apparatus for delivering a prosthesis to a body lumen, said apparatus comprising: a catheter having a passage;a metallic tubular prosthesis carried in the passage at least partially in a radially collapsed configuration, wherein the metallic tubular prosthesis comprises a braided metal structure; anda slidable member in the catheter for advancing the prosthesis from the passage so that said prosthesis everts and radially expands as it is advanced wherein the prosthesis radially expands into engagement with an inner wall of the body lumen and applies a radially outward force against the inner wail as the prosthesis is everted and advanced.
  • 12. The apparatus of claim 11, further comprising a severing member disposed on the delivery catheter adapted to sever the tubular prosthesis thereby allowing a desired length of the severed tubular prosthesis to be released from the delivery catheter while a second portion remains on the delivery catheter.
  • 13. The apparatus of claim 11, wherein the prosthesis carries a therapeutic agent adapted to be released therefrom.
  • 14. The apparatus of claim 13, wherein the therapeutic agent inhibits hyperplasia.
  • 15. The apparatus of claim 11, further comprising an expandable member disposed on the delivery catheter.
  • 16. The apparatus of claim 15, wherein the expandable member comprises a balloon.
  • 17. The apparatus of claim 11, wherein the prosthesis is self-expanding.
  • 18. The apparatus of claim 11, wherein the prosthesis comprises a shape memory alloy.
CROSS-REFERENCES TO RELATED APPLICATIONS

The present application is a continuation of U.S. patent application Ser. No. 10/306,620, filed Nov. 27, 2002, which claims priority to U.S. Provisional Patent Application Ser. No. 60/336,607, filed Dec. 3, 2001, the full disclosures of which are incorporated herein by reference.

US Referenced Citations (211)
Number Name Date Kind
4468224 Enzmann et al. Aug 1984 A
4512338 Balko Apr 1985 A
4564014 Fogarty et al. Jan 1986 A
4580568 Gianturco Apr 1986 A
4681110 Wiktor Jul 1987 A
4733665 Palmz Mar 1988 A
4739762 Palmz Apr 1988 A
4762129 Bonzel Aug 1988 A
4775337 Van Wagener et al. Oct 1988 A
4776337 Palmaz Oct 1988 A
4886062 Wiktor Dec 1989 A
4988356 Crittenden et al. Jan 1991 A
4994066 Voss Feb 1991 A
4994069 Ritchart et al. Feb 1991 A
5013318 Spranza, III May 1991 A
5040548 Yock Aug 1991 A
5092877 Pinchuk Mar 1992 A
5102417 Palmz Apr 1992 A
5104404 Wolff Apr 1992 A
5135535 Kramer Aug 1992 A
5195984 Schatz Mar 1993 A
5217495 Kaplan et al. Jun 1993 A
5226913 Pinchuk Jul 1993 A
5246421 Saab Sep 1993 A
5273536 Savas Dec 1993 A
5282824 Gianturco Feb 1994 A
5300085 Yock Apr 1994 A
5312415 Palermo May 1994 A
5334187 Fischell et al. Aug 1994 A
5421955 Lau et al. Jun 1995 A
5458615 Klemm et al. Oct 1995 A
5478349 Nicholas Dec 1995 A
5490837 Blaeser et al. Feb 1996 A
5496346 Horzewski et al. Mar 1996 A
5501227 Yock Mar 1996 A
5507768 Lau et al. Apr 1996 A
5507771 Gianturco Apr 1996 A
5514093 Ellis et al. May 1996 A
5514154 Lau et al. May 1996 A
5527354 Fontaine et al. Jun 1996 A
5549551 Peacock, III et al. Aug 1996 A
5549563 Kronner Aug 1996 A
5549635 Solar Aug 1996 A
5554181 Das Sep 1996 A
5562725 Schmitt et al. Oct 1996 A
5571086 Kaplan et al. Nov 1996 A
5593412 Martinez et al. Jan 1997 A
5607444 Lam Mar 1997 A
5607463 Schwartz et al. Mar 1997 A
5628775 Jackson et al. May 1997 A
5634928 Fischell et al. Jun 1997 A
5662675 Polanskyj Stockert et al. Sep 1997 A
5676654 Ellis et al. Oct 1997 A
5683451 Lenker et al. Nov 1997 A
5697948 Marin et al. Dec 1997 A
5702418 Ravenscroft Dec 1997 A
5709701 Parodi Jan 1998 A
5722669 Shimizu et al. Mar 1998 A
5723003 Winston et al. Mar 1998 A
5735869 Fernandez-Aceytuno Apr 1998 A
5749848 Jang et al. May 1998 A
5749921 Lenker et al. May 1998 A
5755772 Evans et al. May 1998 A
5755776 Al-Saadon May 1998 A
5755781 Jayaraman May 1998 A
5769882 Fogarty et al. Jun 1998 A
5772669 Vrba Jun 1998 A
5776141 Klein et al. Jul 1998 A
5800519 Sandock Sep 1998 A
5807398 Shaknovich Sep 1998 A
5824040 Cox et al. Oct 1998 A
5824041 Lenker et al. Oct 1998 A
5833694 Poncet Nov 1998 A
5836964 Richter et al. Nov 1998 A
5843092 Heller et al. Dec 1998 A
5858556 Eckert et al. Jan 1999 A
5870381 Kawasaki et al. Feb 1999 A
5879370 Fischell et al. Mar 1999 A
5891190 Boneau Apr 1999 A
5895398 Wensel et al. Apr 1999 A
5899935 Ding May 1999 A
5902332 Schatz May 1999 A
5919175 Sirhan Jul 1999 A
5922020 Klein et al. Jul 1999 A
5961536 Mickley et al. Oct 1999 A
5968069 Dusbabek et al. Oct 1999 A
5976107 Mertens et al. Nov 1999 A
5976155 Foreman et al. Nov 1999 A
5980484 Ressemann et al. Nov 1999 A
5980486 Enger Nov 1999 A
5980514 Kupiecki et al. Nov 1999 A
5980552 Pinchasik et al. Nov 1999 A
5984957 Laptewicz, Jr. et al. Nov 1999 A
6007517 Anderson Dec 1999 A
6022359 Frantzen Feb 2000 A
6033434 Borghi Mar 2000 A
6039721 Johnson et al. Mar 2000 A
6042589 Marianne Mar 2000 A
6056722 Jayaraman May 2000 A
6066155 Amann et al. May 2000 A
6068655 Seguin et al. May 2000 A
6090063 Makower et al. Jul 2000 A
6090136 McDonald et al. Jul 2000 A
6102942 Ahari Aug 2000 A
6106530 Harada Aug 2000 A
RE36857 Euteneuer et al. Sep 2000 E
6120522 Vrba et al. Sep 2000 A
6123712 Di Caprio et al. Sep 2000 A
6123723 Konya et al. Sep 2000 A
6126685 Lenker et al. Oct 2000 A
6129756 Kugler Oct 2000 A
6143016 Bleam et al. Nov 2000 A
6165167 Delaloye Dec 2000 A
6179878 Duering Jan 2001 B1
6187034 Frantzen Feb 2001 B1
6190402 Horton et al. Feb 2001 B1
6196995 Fagan Mar 2001 B1
6200337 Moriuchi et al. Mar 2001 B1
6241691 Ferrera et al. Jun 2001 B1
6251132 Ravenscroft et al. Jun 2001 B1
6251134 Alt et al. Jun 2001 B1
6254612 Hieshima Jul 2001 B1
6254628 Wallace et al. Jul 2001 B1
6258117 Camrud et al. Jul 2001 B1
6267783 Letendre et al. Jul 2001 B1
6273895 Pinchuk et al. Aug 2001 B1
6273913 Wright et al. Aug 2001 B1
6312458 Golds Nov 2001 B1
6315794 Richter Nov 2001 B1
6319277 Rudnick et al. Nov 2001 B1
6325823 Horzewski et al. Dec 2001 B1
6357104 Myers Mar 2002 B1
6375676 Cox Apr 2002 B1
6383171 Gifford et al. May 2002 B1
6419693 Fariabi Jul 2002 B1
6451025 Jervis Sep 2002 B1
6451050 Rudakov et al. Sep 2002 B1
6468298 Pelton Oct 2002 B1
6468299 Stack et al. Oct 2002 B2
6485510 Camrud et al. Nov 2002 B1
6488694 Lau et al. Dec 2002 B1
6488702 Besselink Dec 2002 B1
6511468 Cragg et al. Jan 2003 B1
6520987 Plante Feb 2003 B1
6527789 Lau et al. Mar 2003 B1
6527799 Shanley Mar 2003 B2
6555157 Hossainy Apr 2003 B1
6575993 Yock Jun 2003 B1
6582394 Reiss et al. Jun 2003 B1
6592549 Gerdts et al. Jul 2003 B2
6599296 Gillick et al. Jul 2003 B1
6602282 Yan Aug 2003 B1
6605062 Hurley et al. Aug 2003 B1
6645547 Shekalim et al. Nov 2003 B1
6656212 Ravenscroft et al. Dec 2003 B2
6666883 Seguin et al. Dec 2003 B1
6679909 McIntosh et al. Jan 2004 B2
6692465 Kramer Feb 2004 B2
6702843 Brown Mar 2004 B1
6712827 Ellis et al. Mar 2004 B2
6712845 Hossainy Mar 2004 B2
6723071 Gerdts et al. Apr 2004 B2
6743251 Eder Jun 2004 B1
6800065 Duane et al. Oct 2004 B2
6849084 Rabkin et al. Feb 2005 B2
6899728 Phillips et al. May 2005 B1
7147656 Andreas et al. Dec 2006 B2
20010020154 Bigus et al. Sep 2001 A1
20010020181 Layne Sep 2001 A1
20010044595 Reydel et al. Nov 2001 A1
20020037358 Barry et al. Mar 2002 A1
20020107560 Richter Aug 2002 A1
20020138132 Brown Sep 2002 A1
20020151955 Tran et al. Oct 2002 A1
20020156496 Chermoni Oct 2002 A1
20020177890 Lenker Nov 2002 A1
20020188343 Mathis Dec 2002 A1
20020188347 Mathis Dec 2002 A1
20020193873 Brucker et al. Dec 2002 A1
20030045923 Bashiri et al. Mar 2003 A1
20030093143 Zhao et al. May 2003 A1
20030097169 Brucker et al. May 2003 A1
20030114912 Sequin et al. Jun 2003 A1
20030114919 McQuiston et al. Jun 2003 A1
20030114922 Iwasaka et al. Jun 2003 A1
20030125791 Sequin et al. Jul 2003 A1
20030135266 Chew et al. Jul 2003 A1
20030139796 Sequin et al. Jul 2003 A1
20030139797 Johnson et al. Jul 2003 A1
20030176909 Kusleika Sep 2003 A1
20030199821 Gerdts et al. Oct 2003 A1
20030225446 Hartley Dec 2003 A1
20040087965 Levine et al. May 2004 A1
20040093061 Acosta et al. May 2004 A1
20040093067 Israel May 2004 A1
20040098081 Landreville et al. May 2004 A1
20040186551 Kao et al. Sep 2004 A1
20040215165 Coyle et al. Oct 2004 A1
20040215312 Andreas Oct 2004 A1
20040249435 Andreas et al. Dec 2004 A1
20050010276 Acosta et al. Jan 2005 A1
20050038505 Shuize et al. Feb 2005 A1
20050133164 Andreas et al. Jun 2005 A1
20050149159 Andreas et al. Jul 2005 A1
20050288763 Andreas et al. Dec 2005 A1
20060184235 Rivron et al. Aug 2006 A1
20060229700 Acosta et al. Oct 2006 A1
20060282147 Andreas et al. Dec 2006 A1
20060282150 Olson et al. Dec 2006 A1
20070203566 Arbefeuille et al. Aug 2007 A1
20070213803 Kaplan et al. Sep 2007 A1
Foreign Referenced Citations (28)
Number Date Country
203945 Dec 1986 EP
274129 Jul 1988 EP
282143 Sep 1988 EP
0 505 686 Sep 1992 EP
0 533 960 Mar 1993 EP
0 596 145 May 1997 EP
947180 Oct 1999 EP
1266638 Oct 2005 EP
WO 9633677 Oct 1996 WO
WO 9746174 Dec 1997 WO
WO 9748351 Dec 1997 WO
WO 9901087 Jan 1999 WO
WO 0015151 Mar 2000 WO
WO 0032136 Jun 2000 WO
WO 0041649 Jul 2000 WO
WO 0050116 Aug 2000 WO
WO 0062708 Oct 2000 WO
WO 0072780 Dec 2000 WO
WO 0170297 Sep 2001 WO
WO 0191918 Dec 2001 WO
WO 03022178 Mar 2003 WO
WO 03047651 Jun 2003 WO
WO 03051425 Jun 2003 WO
WO 2004017865 Mar 2004 WO
WO 2004043299 May 2004 WO
WO 2004043301 May 2004 WO
WO 2004043510 May 2004 WO
WO 2004052237 Jun 2004 WO
Related Publications (1)
Number Date Country
20050049673 A1 Mar 2005 US
Provisional Applications (1)
Number Date Country
60336607 Dec 2001 US
Continuations (1)
Number Date Country
Parent 10306620 Nov 2002 US
Child 10966806 US